If you’re desperate for a Spider-Man 4 release date, you’re not the only one! Tom Holland is returning to the MCU, so here’s everything we know about the new movie. Holland first debuted in ...

Even though the stock has become cheaper, we don't have much confidence in Incyte. Here are three reasons why there are better opportunities than INCY and a stock we'd rather own. Founded in 1991 and ...

Incyte INCY also declined after study data disappointed investors. Shares of Sarepta Therapeutics plunged earlier in the week after it reported the death of a patient after treatment with Elevidys ...

Spider-Man 4 will be a "fresh start" for Peter Parker, according to star Tom Holland, so forget everything you know about the character and get ready for a brand-new MCU adventure. The film, which ...

Incyte (NASDAQ:INCY) recently announced that it had achieved positive results from both of its phase 3 studies STOP-HS1 and STOP-HS2. Both of these late-stage studies were using the company's drug ...

Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis ...

Incyte Corporation (INCY), headquartered in Wilmington, Delaware, discovers, develops, and commercializes therapeutics for hematology/oncology, as well as inflammation and autoimmunity areas.

Apr 14, 2023 1:48pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Incyte Corporation - INCY by Newsfile ...